Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Zhang

Showing results (391-400 of 429) with videos related to

Pageof 43
Sort By:
Blood Science (Baltimore, Md.)|April 1, 2025
Prognostic impact of co-mutations in adults with <i>IDH1/2</i>-mutated acute myeloid leukemiaAnli Lai, Wenbing Liu, Chunlin Zhou, et al.
Research (Washington, D.C.)|November 5, 2021
Flexible Diodes/Transistors Based on Tunable p-n-Type Semiconductivity in Graphene/Mn-Co-Ni-O NanocompositesLihong Su, Zhou Yang, Xitong Wang, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2021
Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung CancerJie Shi, Zhiyu Wang, Junping Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
Clonal Architecture of <i>EGFR</i> Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)Xinghao Ai, Jiuwei Cui, Jiexia Zhang, et al.
Haematologica|October 15, 2020
Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemiaHui Wei, Chunlin Zhou, Dong Lin, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|March 24, 2010
Atomic layer deposition-based functionalization of materials for medical and environmental health applicationsRoger J Narayan, Shashishekar P Adiga, Michael J Pellin, et al.
Signal Transduction and Targeted Therapy|December 15, 2024
Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)Xinghao Ai, Bo Jia, Zhiyi He, et al.
Cell Reports|September 15, 2021
Pro-inflammatory and proliferative microglia drive progression of glioblastomaHailong Liu, Youliang Sun, Qian Zhang, et al.
Pageof 43

Showing results (391-400 of 429) with videos related to

Sort By:
Pageof 43
Blood Science (Baltimore, Md.)|April 1, 2025
Prognostic impact of co-mutations in adults with <i>IDH1/2</i>-mutated acute myeloid leukemiaAnli Lai, Wenbing Liu, Chunlin Zhou, et al.
Research (Washington, D.C.)|November 5, 2021
Flexible Diodes/Transistors Based on Tunable p-n-Type Semiconductivity in Graphene/Mn-Co-Ni-O NanocompositesLihong Su, Zhou Yang, Xitong Wang, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2021
Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung CancerJie Shi, Zhiyu Wang, Junping Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
Clonal Architecture of <i>EGFR</i> Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)Xinghao Ai, Jiuwei Cui, Jiexia Zhang, et al.
Haematologica|October 15, 2020
Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemiaHui Wei, Chunlin Zhou, Dong Lin, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|March 24, 2010
Atomic layer deposition-based functionalization of materials for medical and environmental health applicationsRoger J Narayan, Shashishekar P Adiga, Michael J Pellin, et al.
Signal Transduction and Targeted Therapy|December 15, 2024
Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)Xinghao Ai, Bo Jia, Zhiyi He, et al.
Cell Reports|September 15, 2021
Pro-inflammatory and proliferative microglia drive progression of glioblastomaHailong Liu, Youliang Sun, Qian Zhang, et al.
Pageof 43